Ayr Wellness (OTCMKTS:AYRWF - Free Report) had its target price lowered by Roth Mkm from $3.50 to $3.00 in a research report report published on Thursday morning,Benzinga reports. Roth Mkm currently has a buy rating on the stock.
Separately, Roth Capital upgraded Ayr Wellness to a "strong-buy" rating in a research note on Friday, November 8th.
Get Our Latest Report on AYRWF
Ayr Wellness Price Performance
AYRWF stock traded down $0.08 during mid-day trading on Thursday, hitting $0.78. 279,039 shares of the stock were exchanged, compared to its average volume of 292,315. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.75 and a quick ratio of 0.67. The stock has a market capitalization of $89.04 million, a price-to-earnings ratio of -0.42 and a beta of 2.00. The business has a fifty day moving average price of $1.86 and a 200 day moving average price of $2.02. Ayr Wellness has a 12 month low of $0.71 and a 12 month high of $4.09.
Ayr Wellness Company Profile
(
Get Free Report)
Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.
Featured Stories
Before you consider Ayr Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ayr Wellness wasn't on the list.
While Ayr Wellness currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
